- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03288857
Comparison of the Bulb Aspirator to a Nasal Oral Aspirator in the Treatment of Bronchiolitis
April 18, 2019 updated by: Whitney Schwarz, University of Texas at Austin
The investigators aim to compare the standard bulb aspirator with that of a nasal oral aspirator.
The hypothesis is that use of a nasal oral aspirator is more effective at removing nasal secretions in the treatment of bronchiolitis as measured by a predicted 50% decrease in the rate of unscheduled bronchiolitis return visits.
The primary endpoint will be the number of unscheduled bronchiolitis return visits; secondary endpoints will include measurements of oral intake, respiratory relief, parental device preference and adverse events.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study will be a single center, single blind, randomized controlled trial in the pediatric emergency department (ED) at Dell Children's Medical Center of Central Texas (DCMC).
An ED discharge diagnosis of bronchiolitis will trigger patients to be randomized to receive a bulb aspirator or nasal oral aspirator for home secretion management use.
Prior to dispensing the randomized aspirator, a pre-distribution questionnaire will be administered.
Additionally, patients will receive a diary to complete for 3 days post ED discharge.
Research personnel will call families on day 4 as a reminder to return the diary and again on day 14 to obtain a verbal post-study questionnaire.
Research personnel will perform chart review on all patients looking for unscheduled patient return visits for bronchiolitis.
Study Type
Interventional
Enrollment (Actual)
236
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Austin, Texas, United States, 78723
- Dell Children's Medical Center of Central Texas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 month to 2 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children >28 days of life to < 2 years of age discharged home from the DCMC ED with a diagnosis of bronchiolitis (diagnosis made per provider discretion)
- Caregiver fluent in English or Spanish
Exclusion Criteria:
- Previous enrollment
- Hospital admission
- Parental refusal to be randomized to an aspirator device (i.e., family prefers current device and does not wish to be randomized to a potentially different product)
- Current bacterial pneumonia
- Diagnosis of asthma
- Chronic lung disease
- Significant underlying cardiac disease
- Chronic neuromuscular disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Bulb Aspirator
If randomized to the bulb aspirator group, the patient will be sent home with a bulb aspirator to use for home nasal secretion management
|
|
|
Experimental: Nasal Oral Aspirator (NeilMed Naspira)
If randomized to the nasal oral aspirator group, patient will be sent home with a nasal oral aspirator to use for home nasal secretion management
|
NeilMed Naspira is a nasal-oral aspirator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Unscheduled bronchiolitis return visits
Time Frame: 14 days
|
The number of unscheduled bronchiolitis return visits (return to either ED, urgent care or PCP)
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oral intake
Time Frame: 14 days
|
Effects of device on oral intake as determined by diary and post-study questionnaire
|
14 days
|
|
Respiratory relief
Time Frame: 14 days
|
Effects of device on respiratory relief as determined by diary and post-study questionnaire
|
14 days
|
|
Parental device preference
Time Frame: 14 days
|
Parental device preference as determined by diary and post-study questionnaire
|
14 days
|
|
Adverse events
Time Frame: 14 days
|
Description of adverse events as determined by diary and post-study questionnaire
|
14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 22, 2017
Primary Completion (Actual)
March 21, 2019
Study Completion (Actual)
March 21, 2019
Study Registration Dates
First Submitted
September 13, 2017
First Submitted That Met QC Criteria
September 15, 2017
First Posted (Actual)
September 20, 2017
Study Record Updates
Last Update Posted (Actual)
April 19, 2019
Last Update Submitted That Met QC Criteria
April 18, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-06-0086
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchiolitis
-
Regend TherapeuticsShanghai Children's HospitalRecruitingPediatric Bronchiolitis ObliteransChina
-
Fondazione IRCCS Policlinico San Matteo di PaviaCompletedBronchiolitis Obliterans Syndrome (BOS)Italy
-
University Hospital, Basel, SwitzerlandRecruitingBronchiolitis Obliterans Syndrome (BOS) | Bronchiolitis Obliterans (BO)Switzerland, Saudi Arabia
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft vs Host Disease | Constrictive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
Guy's and St Thomas' NHS Foundation TrustCompletedAcute Viral BronchiolitisUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Viral BronchiolitisFrance
-
Ministry of Health, SpainCompleted
-
Shanghai General Hospital, Shanghai Jiao Tong University...Recruiting
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft Versus Host Disease | Graft-Versus-Host Disease | Constructive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
Hillel Yaffe Medical CenterCompletedReflexology | Bronchiolitis; ChemicalIsrael
Clinical Trials on NeilMed Naspira
-
Samuel Lunenfeld Research Institute, Mount Sinai...NeilMed PharmaceuticalsCompletedChronic RhinosinusitisCanada
-
Bridgeport HospitalNeilMed PharmaceuticalsUnknownObstructive Sleep ApneaUnited States
-
University of FloridaNeilMed PharmaceuticalsWithdrawnRhinosinusitis
-
Washington University School of MedicineNot yet recruiting
-
Medical University of South CarolinaNeilMed PharmaceuticalsCompleted
-
Vanderbilt University Medical CenterNeilMed PharmaceuticalsCompleted
-
University of Illinois at ChicagoCures Within ReachRecruitingChronic Rhinosinusitis (Diagnosis)United States
-
St. Paul's Hospital, CanadaWithdrawnChronic Rhinosinusitis (Diagnosis)
-
St. Paul's Hospital, CanadaUnknownChronic Rhinosinusitis With Nasal Polyps | Allergic Fungal Sinusitis